common.study.topics.clinical

MR Spectroscopy and Imaging in Brain Cancers

common.study.values.description

Clinical Development of MR Spectroscopy and Imaging in Brain Cancers

The Investigators will examine the disease specificity of 2-hydroxyglutarate in non-glioma brain lesions, and the clinical utility of 2-hydroxyglutarate, glycine and citrate in isocitrate dehydrogenase (IDH) mutated gliomas and IDH wild type gliomas.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - 3 Tesla Scanning

Approximately 120 brain tumor patients 50 patients with non-glioma disease, and 5 healthy volunteers will be scanned at either 3 Tesla or 7 Tesla.

Device - 7 Tesla Scanning

Approximately 120 brain tumor patients 50 patients with non-glioma disease, and 5 healthy volunteers will be scanned at either 3 Tesla or 7 Tesla.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Clinical Development of MR Spectroscopy and Imaging in Brain Cancers

common.study.values.clinical-trial-id

NCT02731521

participant.views.study.view.id

nel61b